BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18182069)

  • 1. BDNF variability in opioid addicts and response to methadone treatment: preliminary findings.
    de Cid R; Fonseca F; Gratacòs M; Gutierrez F; Martín-Santos R; Estivill X; Torrens M
    Genes Brain Behav; 2008 Jul; 7(5):515-22. PubMed ID: 18182069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression in methadone maintenance treatment patients: rate and risk factors.
    Peles E; Schreiber S; Naumovsky Y; Adelson M
    J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A brain-derived neurotrophic factor haplotype is associated with therapeutic response in obsessive-compulsive disorder.
    Real E; Gratacòs M; Soria V; Escaramís G; Alonso P; Segalàs C; Bayés M; de Cid R; Menchón JM; Estivill X
    Biol Psychiatry; 2009 Oct; 66(7):674-80. PubMed ID: 19589503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes.
    Fonseca F; Gratacòs M; Escaramís G; De Cid R; Martín-Santos R; Fernández-Espejo E; Estivill X; Torrens M
    Mol Diagn Ther; 2010 Jun; 14(3):171-8. PubMed ID: 20560679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals.
    Coller JK; Barratt DT; Dahlen K; Loennechen MH; Somogyi AA
    Clin Pharmacol Ther; 2006 Dec; 80(6):682-90. PubMed ID: 17178268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
    Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
    Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment.
    Crettol S; Besson J; Croquette-Krokar M; Hämmig R; Gothuey I; Monnat M; Déglon JJ; Preisig M; Eap CB
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1722-7. PubMed ID: 18687376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain derived neurotrophic factor gene Val66Met and -270C/T polymorphisms and personality traits predisposing to anorexia nervosa.
    Rybakowski F; Dmitrzak-Weglarz M; Szczepankiewicz A; Skibinska M; Slopien A; Rajewski A; Hauser J
    Neuro Endocrinol Lett; 2007 Apr; 28(2):153-8. PubMed ID: 17435670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Personality changes in opioid-dependent subjects in a methadone maintenance treatment program].
    Trémeau F; Darreye A; Leroy B; Renckly V; Ertlé S; Weibel H; Khidichian F; Macher JP
    Encephale; 2003; 29(4 Pt 1):285-92. PubMed ID: 14615698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders.
    Gratacòs M; Soria V; Urretavizcaya M; González JR; Crespo JM; Bayés M; de Cid R; Menchón JM; Vallejo J; Estivill X
    Pharmacogenomics J; 2008 Apr; 8(2):101-12. PubMed ID: 17505499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered brain-derived neurotrophic factor blood levels and gene variability are associated with anorexia and bulimia.
    Mercader JM; Ribasés M; Gratacòs M; González JR; Bayés M; de Cid R; Badía A; Fernández-Aranda F; Estivill X
    Genes Brain Behav; 2007 Nov; 6(8):706-16. PubMed ID: 17376155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug injecting in patients in New Zealand Methadone Maintenance Treatment programs: an anonymous survey.
    Judson G; Bird R; O'Connor P; Bevin T; Loan R; Schroder M; McGrath R; Weatherall M; Moriarty H; Robinson G
    Drug Alcohol Rev; 2010 Jan; 29(1):41-6. PubMed ID: 20078681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A matched comparison study of medical and psychiatric complications and anesthesia and analgesia requirements in methadone-maintained liver transplant recipients.
    Weinrieb RM; Barnett R; Lynch KG; DePiano M; Atanda A; Olthoff KM
    Liver Transpl; 2004 Jan; 10(1):97-106. PubMed ID: 14755785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the relationship between perceived inter-dose opioid withdrawal and patient characteristics in methadone maintenance treatment.
    Elkader AK; Brands B; Callaghan R; Sproule BA
    Drug Alcohol Depend; 2009 Dec; 105(3):209-14. PubMed ID: 19713051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of BDNF and DRD2 genetic polymorphisms to continued opioid use in patients receiving methadone treatment for opioid use disorder: an observational study.
    Bawor M; Dennis BB; Tan C; Pare G; Varenbut M; Daiter J; Plater C; Worster A; Marsh DC; Steiner M; Anglin R; Desai D; Thabane L; Samaan Z
    Addict Sci Clin Pract; 2015 Oct; 10():19. PubMed ID: 26437921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients.
    Wang SC; Tsou HH; Chen CH; Chen YT; Ho IK; Hsiao CF; Chou SY; Lin YF; Fang KC; Huang CL; Su LW; Fang YC; Liu ML; Wu HY; Lin KM; Liu SC; Kuo HW; Chiang IC; Chen AC; Tian JN; Liu YL
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):695-703. PubMed ID: 22406240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, open-label trial comparing methadone and Levo-Alpha-Acetylmethadol (LAAM) in maintenance treatment of opioid addiction.
    Wolstein J; Gastpar M; Finkbeiner T; Heinrich C; Heitkamp R; Poehlke T; Scherbaum N
    Pharmacopsychiatry; 2009 Jan; 42(1):1-8. PubMed ID: 19153939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for preterm birth among opiate-addicted gravid women in a methadone treatment program.
    Almario CV; Seligman NS; Dysart KC; Berghella V; Baxter JK
    Am J Obstet Gynecol; 2009 Sep; 201(3):326.e1-6. PubMed ID: 19631928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Does maintenance treatment reduce the mortality rate of opioid addicts?].
    Scherbaum N; Specka M; Hauptmann G; Gastpar M
    Fortschr Neurol Psychiatr; 2002 Sep; 70(9):455-61. PubMed ID: 12215918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.